Table 6 Comparison of biochemical parameters at enrolment, 8 weeks, 6 months
Enrolment (n = 52) | 8 weeks (n = 45) | 6 Months (n = 27) | |
|---|---|---|---|
Biochemical parameters | |||
Serum Malondialdehyde (micromole/l) | |||
≤ 3.0 | 0(0%) | 6(13.3%) | 7(25.9%) |
3.1–3.5 | 0(0%) | 13(28.9%) | 7(25.9%) |
3.6–4.0 | 0(0%) | 17(37.8%) | 8(29.6%) |
4.1–4.5 | 0(0%) | 8(17.8%) | 5(18.5%) |
4.6–5.0 | 1(1.9%) | 0(0%) | 0(0%) |
5.1–5.5 | 15(28.9%) | 0(0%) | 0(0%) |
5.6–6.0 | 22(42.3%) | 1(2.2%) | 0(0%) |
> 6.0 | 14(26.9%) | 0(0%) | 0(0%) |
Vitamin C (mg/dl) | |||
< 0.30 (deficiency) | 0(0%) | 0(0%) | 0(0%) |
0.4–0.6 (insufficiency) | 52(100%) | 4(8.9%) | 5(18.5%) |
> 0.6 (sufficiency) | 0(0%) | 41(91.1%) | 22(81.5%) |
Serum cholesterol (mg/dl) (Daniels and Greer 2008; McNeal et al. 2013) | |||
Low(< 125) | 29(55.8%) | 4(8.9%) | 1(3.7%) |
Borderline Low(126–150) | 19(36.5%) | 17(37.8%) | 10(37%) |
Desirable (151–170) | 3(5.8%) | 20(44.4%) | 15(55.6%) |
Borderline(170–199) | 1(1.9%) | 4(8.9%) | 1(3.7%) |
High (> 200) | 0(0%) | 0(0%) | 0(0%) |
High-density lipoprotein (HDL) (35–80 mg/dl) (Daniels and Greer 2008; McNeal et al. 2013) | |||
Undesirable (< 35) | 6(11.5%) | 0(0%) | 3(11.1%) |
Borderline (35–45) | 30(57.7%) | 8(17.8%) | 15(55.6%) |
Desirable (46–55) | 16(30.8%) | 23(51.1%) | 9(33.3%) |
Borderline high (56–70) | 0(0%) | 14(31.1%) | 0(0%) |
Elevated (> 70) | 0(0%) | 0(0%) | 0(0%) |
Low-density lipoprotein (LDL) (mg/dl) (Daniels and Greer 2008; McNeal et al. 2013) | |||
Severely low (51–75) | 40(76.9%) | 15(33.3%) | 9(33.3%) |
Borderline low (76–89) | 9(17.3%) | 19(42.2%) | 12(44.4%) |
Acceptable (90–110) | 3(5.8%) | 11(24.4%) | 6(22.2%) |
Borderline (111–129) | 0(0%) | 0(0%) | 0(0%) |
Undesirable (≥ 130) | 0(0%) | 0(0%) | 0(0%) |
Triglycerides (mg/dl) 5–9 years (Daniels and Greer 2008; McNeal et al. 2013) | |||
Acceptable (50–75) | 22(50%) | 9(23.1%) | 14(63.6%) |
Borderline(76–99) | 17(38.6%) | 20(51.3%) | 8(36.4%) |
High (100–125) | 4(9.1%) | 8(20.5%) | 0(0%) |
Severely high (≥ 125) | 1(2.3%) | 2(5.5%) | 0(0%) |
Triglycerides (mg/dl) 10–12 years (Daniels and Greer 2008; McNeal et al. 2013) | |||
Acceptable (50–90) | 4(50%) | 2(33.3%) | 3(60%) |
Borderline (91–129) | 3(37.5%) | 4(66.4%) | 1(20%) |
High (≥ 130) | 1(12.5%) | 0(0%) | 1(20%) |
Serum calcium (mg/dl) | |||
Low 8.0–8.4 | 16 (30.8%) | 2(4.4%) | 3 (11.1%) |
Normal8.5–8.9 | 26 (50%) | 2(4.4%) | 16 (59.3%) |
Normal 9.0–9.4 | 7 (13.5%) | 20(44.4%) | 8 (29.6%) |
Normal 9.5–9.9 | 3 (5.8%) | 13 (28.9%) | 0 (0%) |
Normal > 10 | 0(0%) | 8 (17.8%) | 0 (0%) |
Serum magnesium (mg/dl) | |||
Low < 1.5 | 0 (0%) | 0 (0%) | 0 (0%) |
Normal 1.5–1.7 | 32 (61.5%) | 3 (6.7%) | 1 (3.7%) |
Normal 1.8–2.2 | 20 (38.5%) | 31 (68.9%) | 22 (81.5%) |
Normal 2.3–2.6 | 0 (0%) | 11 (24.4%) | 4 (14.8%) |